MONTI, VALENTINA
MONTI, VALENTINA
DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)
Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples
2022 I. Capone, F. Bozzi, G.P. Dagrada, P. Verderio, E. Conca, A. Busico, M.A. Testi, V. Monti, M. Duca, C. Proto, S. Damian, A. Piccolo, F. Perrone, E. Tamborini, A. Devecchi, P. Collini, D. Lorenzini, A. Vingiani, L. Agnelli, G. Pruneri
CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)
2020 F. Maura, A. Dodero, C. Carniti, N. Bolli, M. Magni, V. Monti, A. Cabras, D. Leongamornlert, F. Abascal, B. Diamond, B. Rodriguez-Martin, J. Zamora, A. Butler, I. Martincorena, J.M.C. Tubio, P.J. Campbell, A. Chiappella, G. Pruneri, P. Corradini
Comparative assessment of antitumor effects and autophagy induction as a resistance mechanism by cytotoxics and EZH2 inhibition in INI1-negative epithelioid sarcoma patient-derived xenograft
2019 S. Stacchiotti, V. Zuco, M. Tortoreto, D. Cominetti, A.M. Frezza, S. Percio, V. Indio, M. Barisella, V. Monti, S. Brich, A. Astolfi, C. Colombo, S. Pasquali, M. Folini, M.M. Gounder, M.A. Pantaleo, P. Collini, A.P.D. Tos, P.G. Casali, A. Gronchi, N. Zaffaroni
Males with primary biliary cirrhosis manifest enhanced rates of Y chromosome loss compared to healthy subjects
2009 S. Pasini, M. Miozzo, I. Bianchi, V. Monti, E. Rosa Rizzotto, A. Floreani, M. Colombo, C. Selmi, M. Podda, E.M. Gershwin, P. Invernizzi
Serum autoantibodies against cytochrome P450 2EI (CYP2EI) predict severity of liver graft hepatitis C recurrence
2007 C. Rigamonti, M.F. Donato, M. Vidali, F. Agnelli, R. Serino, G. Occhino, A. Ivaldi, E. Arosio, V. Monti, G. Rossi, M. Colombo
Late graft dysfunction (GD) in HBV recurrence-free recipients is associated with serum antinuclear antibodies (ANA) reactivity
2007 M.F. Donato, E. Arosio, V. Monti, F. Agnelli, C. Rigamonti, M. Berra, M. Viganò, G. Rossi, M. Colombo
Serum nuclear autoantibodies with nucleolar pattern in chronic liver diseases
2006 V. Monti, E. Arosio, M.F. Donato, M. Berra, A. Aghemo, M. Colombo
Prevalence of serum antinuclear antibodies (ANA) after liver transplant in HCV and HBV recipients is associated with different clinical profiles
2006 M.F. Donato, E. Arosio, V. Monti, F. Agnelli, C. Rigamonti, M. Berra, M. Colombo
Serum nuclear autoantibodies with nucleolar pattern in chronic liver diseases
2006 V. Monti, E. Arosio, M.F. Donato, M. Berra, A. Aghemo, V. Carbonelli, M. Colombo
Serum autoantibodies correlates with severity of hepatitis c recurrence after liver transplant
2006 M. Donato, E. Arosio, V. Monti, M. Berra, F. Agnelli, C. Rigamonti, G. Rossi, M. Colombo
Serum antinuclear antibodies (ANA) in HCV-related cirrhosis: correlation with liver cell proliferation status and hepatocellular carcinoma (HCC) development
2006 E. Arosio, M. Donato, V. Monti, M. Berra, M. Balestrieri, G. Ronchi, M. Colombo
The international autoimmune hepatitis group scoring system in patients with chronic hepatitis C and serum autoantibodies undergoing interferon/ribavirin therapy : a prospective validation study
2006 V. Monti, A. Aghemo, M. Rumi, M.F. Donato, E. Arosio, R. D’Ambrosio, P. Lampertico, R. Soffredini, M. Colombo
Interferon-alpha suppresses liver cell proliferation in patients with chronic hepatitis C virus infection
2005 M.F. Donato, C. Degott, E. Arosio, M. Martinot, V. Monti, A. Morabito, P. Marcellin, M. Colombo
The prevalence, clinical features and response to antiviral therapy of patients with chronic hepatitis C who are seropositive for liver-kidney microsome type 1 antibodies
2005 V. Monti, A. Aghemo, M.G. Rumi, M.F. Donato, E. Del Ninno, M. Colombo